A Novel Multivalent OspA Vaccine against Lyme Borreliosis Is Safe and Immunogenic in an Adult Population Previously Infected with Borrelia burgdorferi Sensu Lato

Lyme borreliosis (LB) patients who recover, as well as previously infected asymptomatic individuals, remain vulnerable to reinfection with Borrelia burgdorferi sensu lato. There is limited information available about the use of OspA vaccines in this population. In this study, a randomized double-bli...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
الحاوية / القاعدة:Clin Vaccine Immunol
المؤلفون الرئيسيون: Wressnigg, Nina, Barrett, P. Noel, Pöllabauer, Eva-Maria, O'Rourke, Maria, Portsmouth, Daniel, Schwendinger, Michael G., Crowe, Brian A., Livey, Ian, Dvorak, Thomas, Schmitt, Bernhard, Zeitlinger, Markus, Kollaritsch, Herwig, Esen, Meral, Kremsner, Peter G., Jelinek, Tomas, Aschoff, Roland, Weisser, Roland, Naudts, Ingomar F. K., Aichinger, Gerald
التنسيق: Artigo
اللغة:Inglês
منشور في: American Society for Microbiology 2014
الموضوعات:
Vaccines
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC4248771/
https://ncbi.nlm.nih.gov/pubmed/25185574
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/CVI.00406-14
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة